Wyniki wyszukiwania:

About the Contributor(s):
Lodovico Balducci is a physician, medical oncologist, Senior Member of the Moffitt Cancer Center, and he is Professor of Medicine and Oncologic Science at the University of South Florida in Tampa. He is considered the father of geriatric oncology, a discipline he developed and publicized over the past twenty-five years. He is the senior editor of three textbooks of geriatric oncology and two textbooks of geriatric hematology.

Biological Basis of Geriatric Oncology highlights research issues that are specific to geriatric oncology in the field of carcinogenesis and cancer prevention and treatment, based on the biologic interactions of cancer and age. It illustrates the benefit of the principles of geriatrics in the management of cancer in the older individual.

This volume provides a frame of reference for practicioners of any specialties involved in the management of older patients and for oncologists involved in the management of cancer of older individuals. It is a source for basic and clinical...

Biological Basis of Geriatric Oncology highlights research issues that are specific to geriatric oncology in the field of carcinogenesis and cancer prevention and treatment, based on the biologic interactions of cancer and age. It illustrates the benefit of the principles of geriatrics in the management of cancer in the older individual.

This volume provides a frame of reference for practicioners of any specialties involved in the management of older patients and for oncologists involved in the management of cancer of older individuals. It is a source for basic and clinical...

Anemia in the elderly has been properly defined as the silent epidemic, representing 3 million people in the United States aged 65 years and older. Incidence and prevalence of this condition increase with age. It differs in its etiology, pathogenesis and treatment from anemia in children and younger adults. Anemia is associated with reduced survival, increased risk of functional dependence and hospitalization, increased risk of congestive heart failure and stage renal disease and cognitive disorders. Approximately 70% of anemia in older individuals is reversible.

Anemia in the elderly has been properly defined as the silent epidemic, representing 3 million people in the United States aged 65 years and older. Incidence and prevalence of this condition increase with age. It differs in its etiology, pathogenesis and treatment from anemia in children and younger adults.

About the Contributor(s): Lodovico Balducci is a physician, medical oncologist, Senior Member of the Moffitt Cancer Center, and he is Professor of Medicine and Oncologic Science at the University of South Florida in Tampa. He is considered the father of geriatric oncology, a discipline he developed and publicized over the past twenty-five years. He is the senior editor of three textbooks of geriatric oncology and two textbooks of geriatric hematology.